Dental Tribune U.S. Edition No. 3, 2018

IMPLANT TRIBUNE The World’s Dental Implant Newspaper · U.S. Edition MARCH 2018 — Vol. 13, No. 3 www.dental-tribune.com AO ‘plays’ in LA Los Angeles will be the site of the Academy of Osseointegration Annual Meeting from Feb. 28-March 3. Photo/Provided by www.freeimages.com. Debate, increased audience participation among the new features for 2018 session By AO Staff A ttendees of the Academy of Osseointegration’s (AO) An- nual Meeting will not only experience the glitz and glamour of Hollywood but, more im- portantly, unparalleled substance from this premier, four-day scientific meet- ing. Session dates are Feb. 28-March 3. While an impressive lineup of lectur- ers will drive home the 2018 theme of “Inspiring Imagination and Enhancing Health,” attendees will really notice the difference in the 2018 program via a significantly more collaborative forum and the opportunity to engage with AO’s captivating, world-renowned speakers in lively, real-time discussions. Specifically, this will include: • Concurrent surgical and restorative point-counterpoint sessions. To delin- eate the reality and myths on current controversial topics in implant dentistry, panelists will present their viewpoint in a short presentation. Afterwards, expert clinician moderators will promote de- bate and attempt to draw meaningful conclusions. • A new “Reflection Panel” as part of the closing session. During this segment, AO President Dr. Michael Norton will mod- erate a panel discussion with what you might call “the wise of implant dentist- ry” that will feature Drs. Tomas Albrekts- son, David Cochran, Ole Jensen, Stephen Parel and Dennis Tarnow who will reflect on the past and future of implant ther- apy. This portion of the closing session will not involve lectures at all. “This is brand new for AO, and I would contend a new concept for any dental congress to have a whole session purely dedicated to debate. What’s more, it’s planned for maximum audience partici- pation, so every delegate can have their say,” Norton said. • Also new this year is a “Lunch with the Masters” program on Saturday. Featur- ing Drs. Paulo Malo, Isabella Rocchietta, Giovanni Zucchelli, Christian Coachman and Stephen Chu, the topics discussed at these luncheons will include an update on All-on-4, guided bone regeneration, natural teeth gingival defects, digital es- thetics and platform switching. In addition to these enhancements that will enrich their annual meeting ex- perience, attendees will also come to find the customary favorites as part of the schedule. These will include innovative and groundbreaking research presenta- tions via the oral clinical and oral scien- tific research and clinical innovations sessions with more than 250 abstracts and e-poster presentations, corporate fo- rums, the Morning with the Masters se- ries, programming for young clinicians and global networking. Reflective of its reputation as the global multi-disciplinary nexus for implant dentistry, AO’s 2018 Annual Meeting will be the perfect place where specialists, general practitioners, lab technicians and dental hygienists will gather to con- tribute their knowledge and share best practices. There will be something for everyone, so be sure to register today at meetings. osseo.org/2018. JOMS study: Mouth cancer tests help uncover other issues By JOMS Staff Tests used to guide treatment for mouth cancers can reveal two or more significant health conditions, allow- ing doctors to better evaluate those patients, according to a new study. Typically conducted during the ini- tial steps of cancer treatment plans, these exams for oral squamous cell carcinoma (OSCC) help discover co- morbidities — the presence of one or more conditions existing with a primary disorder —in patients with OSCC (cancer in cells in the lips and oral cavity), researchers said. Clinicians should evaluate previ- ously undiagnosed conditions found on imaging studies, researchers rec- ommend in the study published in January’s Journal of Oral and Maxil- lofacial Surgery – the official journal of the American Association of Oral and Maxillofacial Surgeons. “Within the limitations of this study, it can be concluded that imag- ing staging examinations facilitate, accelerate and improve the pre- therapeutic diagnostic process in pa- tients with OSCC, which enables clini- cians to assess patients more accurate- ly and provide tailored and individual treatment plans,” researchers wrote. The study involved 178 adults with OSCC who underwent a commonly used staging examination — fluo- rodeoxyglucose positron-emission tomographic computed tomography (FDG-PET/CT) or contrast-enhanced computed tomography (ceCT). Re- searchers used the Charlson Comor- bidity Index (CCI) to measure comor- bidity before and after staging. The authors of “Comorbidity As- sessment in Patients With Oral Squa- mous Cell Carcinoma: Can Imaging Techniques Provide Additional In- formation?” are Matthias Troelt- zsch, MD, DMD, and Florian Andreas Probst, MD, DMD. The complete article can be ac- at www.joms.org/article/ cessed S0278-2391(17)30601-8/fulltext.

Dental Tribune U.S. Edition No. 3, 2018

Pages Overview